Vimarsana
Biggest News Aggregation in the World

Page 5 - Vela Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vela Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vela Diagnostics Today - Breaking & Trending Today

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™

Hepatitis Testing Market worth $3.6 billion by 2026 – Exclusive Report by MarketsandMarkets™

Healthcare providers can expect to receive US$725 reimbursement from CMS when using NGS-based Sentosa(R) SQ HIV-1 Genotyping Assay - Vimarsana News

Healthcare providers can expect to receive US$725 reimbursement from CMS when using NGS-based Sentosa(R) SQ HIV-1 Genotyping Assay

/PRNewswire/ -- Vela Diagnostics announced that its Sentosa® SQ HIV-1 Genotyping Assay is covered for reimbursement from The Centers for Medicare and Medicaid...

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis),...

Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy - Vimarsana News

Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy

Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy USA - English Share this article Share this article SINGAPORE, June 3, 2021 /PRNewswire/ -- Vela Diagnostics announced a collaboration with the National Cancer Centre of Singapore (NCCS) to develop a molecular diagnostic assay to predict individual patients' responses to a cancer therapy called Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs). Being able to predict an individual's response will help clinicians determine if EGFR-TKIs are a suitable the...

Molecular Diagnostics Market worth $31.8 billion by 2026 - Exclusive Report by MarketsandMarkets - Vimarsana News

Molecular Diagnostics Market worth $31.8 billion by 2026 - Exclusive Report by MarketsandMarkets

Molecular Diagnostics Market worth $31.8 billion by 2026 - Exclusive Report by MarketsandMarkets "Molecular Diagnostics Market by Product & Service(Reagents, Kits, PoC & Tabletop Instruments), Application(COVID-19, Hepatitis, HAI, HIV, Oncology, Genetic Tests), Technology (PCR, NGS, ISH), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2026", published by MarketsandMarkets, the global market is projected to reach USD 31.8 billion by 2026 from USD 17.8 billion in 2021, at a 12.3% CAGR. Browse in-depth TOC on Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.a...